Nature's Sunshine targets $1B sales and 15% EBITDA margin as it reiterates 2026 $500M-$515M outlook
Nature's Sunshine Products Inc. · PHARMACEUTICAL PREPARATIONS · Now $20.80
-9.4% in 7d after detection
Post-detection moves
1h
—
1d
-1.3%
3d
-8.6%
7d
-9.4%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS